Form 4 holding
Chief Financial Officer, Director
Raphael Pharmaceutical Inc.
- Security class
- Common Stock
- Shares / value
- 1,266,455
- Estimated value
- $633,228
- Report date
- 26 Jul 2022
- Price
- $0.5000
- Ownership
- Direct
Guy Ofir
Insider Reports History
- Reporting-owner location
- Karmiel, Israel
- Latest reporting-owner signature
-
/s/ Guy Ofir
Source: Latest parsed Forms 3/4/5 signature
- Transaction source note
- Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.
Identity
Names, identifiers, and filing context for this profile.
1 identity field
SEC source record
Original filing metadata and source links for verification.
1 source field
Source evidence
Original filing metadata and source links for verification.
1 source field
Reported holdings for Guy Ofir
Form 4 holding
Chief Financial Officer, Director
Raphael Pharmaceutical Inc.
- Security class
- Warrants to Purchase Common Stock
- Shares / value
- 1,000,000
- Estimated value
- Report date
- 05 Dec 2022
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Insider Reports Filed by Guy Ofir
4
RAPH
Raphael Pharmaceutical Inc.
- Report period
- 26 Jul 2022
- Transactions
- 2
- Transaction value
- $0
- Accepted by SEC
- 13 Mar 2023, 16:01
- Role
- Chief Financial Officer, Director
- Next action
- Open filing details
3
RAPH
Raphael Pharmaceutical Inc.
- Report period
- 27 Sep 2021
- Transactions
- 0
- Transaction value
- $0
- Accepted by SEC
- 19 Nov 2021, 11:51
- Role
- Chief Financial Officer, Director
- Next action
- Open filing details